Human CellExp™ SARS-CoV-2 Spike RBD (K417N, E484K, N501Y) from BIOVISION, INC.

Search, find, compare suppliers for Human CellExp™ SARS-CoV-2 Spike RBD (K417N, E484K, N501Y) products.

Edit 
Product NameHuman CellExp™ SARS-CoV-2 Spike RBD (K417N, E484K, N501Y)
DescriptionThe target protein SARS-CoV-2 S Protein RBD (K417N, E484K, N501Y) is expressed with His tag at the C-terminus. Purity ≥ 90% by SDS-PAGE. SARS-CoV-2 Spike protein is a large type I transmembrane protein composed of S1 subunit and S2 subunit. During viral infection, the receptor-binding domain (RBD) of the S1 subunit is responsible for the recognition and binding of host receptor ACE2, while the S2 subunit mediates viral cell membrane fusion. The SARS-CoV-2-S1-RBD/ACE2 interaction mediates viral entry into the target cells. The 501Y.V2 variant or lineage B.1.351 was first detected in South Africa. The variant contains three spike receptor binding site mutations (K417N, E484K and N501Y) that have been shown to mildly increase receptor binding. MW: 35 kDa
Size50 µg
Concentrationn/a
ApplicationsRUO
Other NamesCOVID-19 Spike RBD protein (K417N, E484K, N501Y); 2019-nCoV Spike RBD protein (K417N, E484K, N501Y); SARS-CoV-2 Mutant (K417N, E484K, N501Y); SARS-CoV-2 (K417N, E484K, N501Y) mutant protein; South African (ZA) variant (501Y.V2, B.1.351)
Gene, Accession, CAS #Accession: YP 009724390.1
Catalog #P1645-50
Price$345
Order / More InfoHuman CellExp™ SARS-CoV-2 Spike RBD (K417N, E484K, N501Y) from BIOVISION, INC.
Product Specific Referencesn/a
BIOVISION, INC.
BIOVISION, INC.
BIOVISION, INC.
155 S. Milpitas Boulevard
Milpitas CA 95035
P: 408-493-1800
P: 800-891-9699
F: 408-493-1801

support@biovision.com

http://www.biovision.com

Facebook
Twitter
LinkedIn


Profile of BIOVISION, INC.
Return to Products

© 1980 - 2021 Linscott's Directory, Linscott's USA. All rights reserved.